Literature DB >> 2232938

Nutritional intervention studies in cancer prevention.

L E Holm1.   

Abstract

Nutritional intervention trials are important tools in the search for efficient cancer prevention strategies. They can be divided into two types of trials; chemoprevention in which intervention is a defined chemical agent or a micronutrient, and diet trials in which intervention is a change in dietary habits. The most commonly used chemopreventive agents are retinoids, beta-carotene, and vitamins. The chemopreventive trials are directed to general cancer prevention or focus on target organs. The diet intervention studies include subjects at increased risk for cancer, cancer patients and community-based intervention programs. Although several completed chemopreventive studies indicate that certain micronutrients can prevent neoplastic growth, the follow-up period is still too short for most nutritional intervention studies to determine whether their preventive strategies are effective.

Entities:  

Mesh:

Year:  1990        PMID: 2232938     DOI: 10.1007/bf02988550

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  24 in total

1.  The National Cancer Institute's intervention trials.

Authors:  J W Cullen
Journal:  Cancer       Date:  1988-10-15       Impact factor: 6.860

2.  Feasibility of a randomized trial of a low-fat diet for the prevention of breast cancer: dietary compliance in the Women's Health Trial Vanguard Study.

Authors:  M M Henderson; L H Kushi; D J Thompson; S L Gorbach; C K Clifford; W Insull; M Moskowitz; R S Thompson
Journal:  Prev Med       Date:  1990-03       Impact factor: 4.018

3.  A breast cancer Nutrition Adjuvant Study (NAS): protocol design and initial patient adherence.

Authors:  R T Chlebowski; D W Nixon; G L Blackburn; P Jochimsen; E F Scanlon; W Insull; I M Buzzard; R Elashoff; R Butrum; E L Wynder
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

Review 4.  Rationale and strategies for chemoprevention of cancer in humans.

Authors:  J S Bertram; L N Kolonel; F L Meyskens
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

5.  Etretinate in treatment of actinic keratosis. A double-blind crossover study.

Authors:  M Moriarty; J Dunn; A Darragh; R Lambe; I Brick
Journal:  Lancet       Date:  1982-02-13       Impact factor: 79.321

6.  A strategy for cancer prevention and control research.

Authors:  P Greenwald; C E Caban
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

7.  Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatment.

Authors:  J L Misset; G Mathé; G Santelli; J Gouveia; J P Homasson; M C Sudre; H Gaget
Journal:  Cancer Detect Prev       Date:  1986

8.  A phase I trial of beta-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia.

Authors:  F L Meyskens; V Graham; M Chvapil; R T Dorr; D S Alberts; E A Surwit
Journal:  J Natl Cancer Inst       Date:  1983-11       Impact factor: 13.506

9.  The effect of vitamin E on mammary dysplasia: a double-blind study.

Authors:  R S London; G S Sundaram; L Murphy; S Manimekalai; M Reynolds; P J Goldstein
Journal:  Obstet Gynecol       Date:  1985-01       Impact factor: 7.661

10.  Activity of isotretinoin against squamous cell cancers and preneoplastic lesions.

Authors:  F L Meyskens; E Gilmartin; D S Alberts; N S Levine; R Brooks; S E Salmon; E A Surwit
Journal:  Cancer Treat Rep       Date:  1982-06
View more
  1 in total

1.  Olive oil prevents benzo(a)pyrene [B(a)P]-induced colon carcinogenesis through altered B(a)P metabolism and decreased oxidative damage in Apc(Min) mouse model.

Authors:  Leah D Banks; Priscilla Amoah; Mohammad S Niaz; Mary K Washington; Samuel E Adunyah; Aramandla Ramesh
Journal:  J Nutr Biochem       Date:  2015-10-22       Impact factor: 6.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.